SLC5A2 and hydrops fetalis: Screen and treat CV and non-CV comorbidities (I)Diuretics—for fluid overload (I)SGLT2 inhibitors—dapagliflozin or empagliflozin (I)ARNI, ARB, beta-blocker, MRA—consider in select patients to reduce risk of HF hospitalization and death (IIb)Multidisciplinary interventions:• Enrolment into multidisciplinary team HF management program (I)• Self-management strategies (I)• Influenza and pneumococcal vaccinations (IIa)Exercise rehabilitation:• Regular exercise (I)• Cardiac rehabilitation programme (IIa)